clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
Clinical OMICs Live
Virtual Event
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Companies
PathAI Broadens Diagnostics Portfolio with Poplar Acquisition
Oncology
Mutations from Thiopurines May Cause ALL to Relapse
Translational Research
Autism Spectrum Disorder in Children Linked to Non-Diet-Influenced Features of Gut…
RNA Sequencing
Three-Platform Approach Brings Precision Medicine Closer for Children with Cancer
Precision Medicine
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
New Products
Enzymatic Fragmentation Library Preparation Kit
Companies
PathAI Broadens Diagnostics Portfolio with Poplar Acquisition
Oncology
Mutations from Thiopurines May Cause ALL to Relapse
Translational Research
Autism Spectrum Disorder in Children Linked to Non-Diet-Influenced Features of Gut…
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
All
Clinical OMICs Live
Virtual Event
Webinars
eBooks
Virtual Event
From Detection to Testing: Utilizing NGS to Power Precision Medicine
Upcoming Webinars
Early Cancer Recurrence Detection: A Tumor-Informed Approach
eBooks
Unlocking the Cancer Code
Clinical OMICs Live
The GENOME ODYSSEY: Solving Medical Mysteries with Euan Ashley, MD, PhD
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Precision Medicine
Companies
Companies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Companies
PathAI Broadens Diagnostics Portfolio with Poplar Acquisition
July 27, 2021
Companies
The Long and the Short of It: PacBio Strikes $800M Deal...
July 21, 2021
Companies
Direct To Consumer Testing for Familial Hypercholesterolemia: Helpful or Misleading?
July 19, 2021
Companies
Rady Children’s and Takeda Partner to Develop Treatments for Rare Genetic...
July 16, 2021
Companies
Thermo Fisher, UC Davis Launch Clinical Metabolomics Center
July 15, 2021
Companies
Woodcock: FDA Staff-Biogen Communications Leading to AD Drug Approval Needs Independent...
July 12, 2021
Companies
Sophia Genetics to Collaborate with GE Healthcare to Advance Precision Cancer...
July 8, 2021
Companies
In-Surgery Classification of Brain Tumors
July 1, 2021
Companies
Sequencing and COVID-19: From Genomic Epidemiology to Host Response
July 1, 2021
Companies
Old Antibiotic Targets BRCA-Mutated, PARP Inhibitor-Resistant Tumors
June 18, 2021
Load more
Featured
Treating Ultrarare Diseases, One Patient at a Time
April 9, 2021
Sponsored: Making NGS Actionable—Moving Oncology Beyond ‘One Mutation-One Drug’
June 24, 2021
Hunting for Hereditary Cancers
April 9, 2021
New Products
View More
Enzymatic Fragmentation Library Preparation Kit
July 27, 2021
Direct RNA Amplification Reagents
April 13, 2021
Bioinformatics for Multi-Omics Discovery at Massive Scale
March 15, 2021
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1218-218x150.jpeg "Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies")
